Interpretability is the differentiator here: dosing models that explain their predictions are far easier to slot into clinical workflows than black-box alternatives, which matters in transplant medicine where tacrolimus has a narrow therapeutic window. Clinicians, clinical pharmacists and hospital AI teams evaluating decision-support tools can use the paper as a reference design for explainable dose recommendations.
Autonomous ultrasound robots moving into prospective multicenter trials signal that AI-guided screening is graduating from lab demos to clinical evidence. Clinicians and medtech teams tracking diagnostic imaging automation can use this study as a reference point for regulatory-grade validation. Readers can compare its trial design with other autonomous imaging systems heading toward approval.
想知道现在那些健康类 AI 到底能不能帮患者走完就医流程？这篇 npj Digital Medicine 的论文用了患者旅程这套评估框架，做医疗方向的人可以看看。
npj Digital Medicine 的新论文，讲医院上了编排平台之后怎么靠结构化变更管理让 AI 真正用起来，做医疗信息化的可以看看。